Syndax Pharmaceuticals Inc
XNAS: SNDX
Syndax Pharmaceuticals Inc Live Stock Price Today, Share Analysis and Chart
about
Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. Its product candidates include revumenib and axatilimab. It is developing revumenib, a ...
Read More
17.73
2.01
(12.79%)
3.5M
XNAS Volume
XNAS 11 Nov, 2025 4:17 PM (EST)
Board Meeting
The next board meeting for Syndax Pharmaceuticals Inc is on 20 Nov 2025 for the purpose of Jefferies 2025 London Healthcare Conference
See details
Low Financial Strength
Expensive Valuation
Technically Moderately Bullish
Momentum Trap
These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked.
View Similar
Embed DVM
Syndax Pharmaceuticals Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..